Seed money to Karl Gisslander´s project about ANCA-associated vasculitis
EpiHealth has decided to support the next generation researchers in epidemiology through seeding funding that will cover salary costs for preparation of a project application and a research plan targeting national funding bodies. One of the five recipients is Karl Gisslander. His project is about the rare but life-threatening disease anti-neutrophil cytoplasmic antibody (ANCA) associated vasculiti
https://www.epihealth.lu.se/en/article/seed-money-karl-gisslanders-project-about-anca-associated-vasculitis - 2025-10-05